In conclusion, this study suggests that knockdown of SALL4 inhibits the proliferation of MCF-7/ADR cells through arresting the cell cycle in the G1 phase and that down-regulation of SALL4 reverses the drug resistance of breast cancer by reducing the expression of ABCG2 and c-myc. The gene discussed is MYC; the disease is breast carcinoma.